In the field of aesthetics, Melanotan-II has garnered significant attention for its ability to induce melanin production and darken the skin. Numerous studies have focused on evaluating its efficacy and safety regarding sun protection and cosmetic use. Clinical trials indicate that Melanotan-II can increase skin melanin levels independently of ultraviolet (UV) exposure, thereby enhancing the skin's resistance to UV radiation and reducing the risk of sunburn and skin cancer. However, its use entails potential risks, such as uneven skin pigmentation and a possible-though not yet fully established-risk of skin cancer. In the medical realm, Melanotan-II has demonstrated therapeutic potential for certain conditions.
For instance, in patients with photosensitivity disorders (such as erythropoietic protoporphyria), increasing skin melanin levels holds promise for alleviating light sensitivity and improving symptoms. Furthermore, Melanotan-II is being investigated as a potential treatment for sexual dysfunction; some clinical studies suggest it may improve male erectile dysfunction and female low libido, although further large-scale, long-term clinical trials are required to definitively establish its efficacy and safety. Meanwhile, scientists are actively exploring structural optimization of Melanotan-II, modifying its amino acid sequence to develop analogs with enhanced activity, safety, and specificity.